News
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
Vertex Pharmaceuticals (NASDAQ: VRTX) is already a rock star in the world of cystic fibrosis (CF) treatment. The company's drugs have been life-changing for children and adults living with the
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
Vertex Pharmaceuticals (NASDAQ: VRTX) is already a rock star in the world of cystic fibrosis (CF) treatment. The company's drugs have been life-changing for children and adults living with the
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Is the Worst Over for Novavax?
In the early days of the COVID-19 pandemic, Novavax (NASDAQ: NVAX) took center stage. The biotech company became one of the first to enter clinical trials with a coronavirus vaccine candidate. And
2 Cathie Wood Stocks That Can Get You Through Any Recession
Economists at the U.S. Federal Reserve recently uttered the dreaded "R" word. They are now predicting a recession will come later this year. Investors have been bracing for this possibility for a
2 Cathie Wood Stocks That Can Get You Through Any Recession
Economists at the U.S. Federal Reserve recently uttered the dreaded "R" word. They are now predicting a recession will come later this year. Investors have been bracing for this possibility for a
2 Cathie Wood Stocks That Can Get You Through Any Recession
Economists at the U.S. Federal Reserve recently uttered the dreaded "R" word. They are now predicting a recession will come later this year. Investors have been bracing for this possibility for a
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Exelixis (EXEL) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Exelixis (NASDAQ: EXEL)Q1 2023 Earnings CallMay 09, 2023, 5:00 p.m. ET
Operator
Source Fool.com
MacroGenics (MGNX) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
MacroGenics (NASDAQ: MGNX)Q1 2023 Earnings CallMay 09, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Agenus (AGEN) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Agenus (NASDAQ: AGEN)Q1 2023 Earnings CallMay 09, 2023, 8:30 a.m. ET
Operator
Source Fool.com
Why Viking Therapeutics Stock Wobbled Today
Shares of clinical-stage biotech Viking Therapeutics (NASDAQ: VKTX) fell by as much as 4.8% on exceptionally low volume during the first hour of trading Tuesday morning. Since this mid-single-digit
Why Shares of Grifols Were Up Tuesday
Shares of Grifols (NASDAQ: GRFS) were up 11.1% on Tuesday afternoon, after being up as much as 13.1% earlier in the day. The pharmaceutical company, which makes plasma-derived medicines, released
Axsome's New Drug Is Scoring a Win. Is the Stock a Buy?
Axsome Therapeutics (NASDAQ: AXSM) stood out last year. The biotech began selling its first two products: Sunosi, a sleep disorder drug it acquired from Jazz Pharmaceuticals; and Auvelity, an
Why CRISPR Therapeutics Stock Is on Fire Today
Shares of the developmental gene-editing company CRISPR Therapeutics (NASDAQ: CRSP) were up by 12.4% on sky-high volume as of 1:46 p.m. ET Tuesday afternoon. The big gain came in response to the bio
Why CRISPR Therapeutics Stock Is on Fire Today
Shares of the developmental gene-editing company CRISPR Therapeutics (NASDAQ: CRSP) were up by 12.4% on sky-high volume as of 1:46 p.m. ET Tuesday afternoon. The big gain came in response to the bio
Why CRISPR Therapeutics Stock Is on Fire Today
Shares of the developmental gene-editing company CRISPR Therapeutics (NASDAQ: CRSP) were up by 12.4% on sky-high volume as of 1:46 p.m. ET Tuesday afternoon. The big gain came in response to the bio
EQS-News: Just – Evotec Biologics launches tech partnership for biosimilars development and commercial manufacturing
EQS-Adhoc: Just – Evotec Biologics enters strategic biosimilars partnership with Sandoz
The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings
EQS-News: Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings
Axsome Therapeutics (AXSM) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Axsome Therapeutics (NASDAQ: AXSM)Q1 2023 Earnings CallMay 08, 2023, 8:00 a.m. ET
Operator
Source Fool.com
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
2 Top Healthcare Stocks Defying the Bear Market
Eli Lilly (NYSE: LLY) and Merck (NYSE: MRK) have seen their shares rise by over 17% and 5%, respectively, this year while the S&P 500 Health Care Sector Index has dropped 1.7%. What's interesting